Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.401
Delayed Data
As of Aug 31
 +0.006 / +1.52%
Today’s Change
0.34
Today|||52-Week Range
3.98
-74.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Revenue and IncomeNet Revenues97.0K399.0K71.0K--
 
 
 
 
Depreciation And Amortization147.0K99.0K87.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.9M21.2M8.8M--
 
 
 
 
Research And Development10.5M17.7M5.7M--
 
 
 
 
Total Operating Expenses13.1M21.3M8.9M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-20.9M-8.8M--
 
 
 
 
Extraordinary Credit13.0K0.00----
 
 
Interest Expense On Debt30.0K0.000.00--
 
 
Other Expenses125.0K0.009.0K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.9M-20.9M-8.8M--
 
 
 
 
Preferred Dividend-12.8M-8.6M-4.1M--
 
 
 
 
Net Income-12.9M-20.9M-8.8M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.6M10.3M16.4M--
 
 
 
 
Shares To Calculate EPS Diluted4.6M10.3M16.4M--
 
 
 
 
 
Earnings Per ShareEPS-$5.70-$2.88-$0.79--
 
 
 
 
EPS Diluted-$5.70-$2.88-$0.79--